Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × Salpingectomy × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Surgery 1 Ovarian Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1

Interventions

Bevacizumab 29 Paclitaxel 26 olaparib 23 pembrolizumab 21 Specimen Handling 20 Carboplatin 20 Magnetic Resonance Spectroscopy 14 Gemcitabine 12 Biopsy 12 liposomal doxorubicin 11 Taxes 11 Cyclophosphamide 11 Cisplatin 10 niraparib 9 Fulvestrant 9 fludarabine 7 Doxorubicin 6 Topotecan 5 Oxaliplatin 5 Nivolumab 5 Immunoglobulin G 5 Disulfides 5 trastuzumab deruxtecan 4 palbociclib 4 durvalumab 4 atezolizumab 4 aldesleukin 4 X-Rays 4 Standard of Care 4 Platinum 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03045965 2026-02-17

HOPPSA

Göteborg University

Phase NA Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡